Search
Imunon Inc
IMNNAdd to Watchlist
1.480USD
-0.030-1.99%
Market hours 09/23, 12:46（ET）
6.22MMarket Cap
LossP/E TTM
Imunon Inc (IMNN) Stock Price Target & Forecast
Analyst Rating
Based on 4 analysts giving stock ratings to Imunon Inc in the past month.
Buy
0 Strong Buy
4 Buy
0 Hold
0 Sell
0 Strong Sell
Target Price
17.000USD+1150.00%
IMNN Analyst Recommendation Trends
In the current month, IMNN has received 4 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. IMNN average Analyst price target in the last month is 17.000.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
4
4
4
4
4
3
3
3
0
0
0
0
0
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
4
4
4
4
4
4
IMNN Analyst Rating for Peer Comparison
Updated: Sep 22, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
argenx SE
ARGX
11
14
3
0
0
28
Beigene Ltd
ONC
8
19
0
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
14
6
0
0
26
Insmed Inc
INSM
7
17
0
0
0
24
IQVIA Holdings Inc
IQV
8
12
4
0
0
24
Kymera Therapeutics Inc
KYMR
8
13
2
0
0
23
Cytokinetics Inc
CYTK
4
16
2
0
0
22
CRISPR Therapeutics AG
CRSP
4
8
10
0
0
22
Revolution Medicines Inc
RVMD
8
13
1
0
0
22
Tempus AI Inc
TEM
5
7
7
1
1
21
Financial Forecasting
Based on analysts' estimates, IMNN EPS is projected to reach -0.552 in FY2026Q3, following reported EPS of -0.541 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-1.17
-1.11
-0.93
-0.55
-0.48
Actual
-2.02
-0.84
-0.54
--
--
Surprise
-72.06%
+23.88%
+41.55%
--
--
FAQs
What is Imunon Inc's price target?
Analysts forecast that Imunon Inc's price target is USD 17.00, with the highest forecast at USD 25.00 and the lowest forecast at USD 10.00.
How have Imunon IncIMNN's recent earnings per share performed?
The market expectation was USD -0.54, while Imunon IncIMNN's earnings per share (EPS) for the previous quarter was USD -0.84. EPS for the next quarter is expected at USD -0.55.
What is the analyst rating for Imunon Inc?
Based on the ratings of Imunon Inc's stock from 4 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.